- Home
- CLLS vs CANG Comparison
CLLS vs CANG Comparison
Compare CLLS & CANG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLLS | CANG |
|---|---|---|
| Founded | 1999 | 2010 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 438.4M | 457.2M |
| IPO Year | 2007 | 2018 |
Fundamental Metrics
Financial Performance| Metric | CLLS | CANG |
|---|---|---|
| Price | $3.54 | $1.17 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $8.50 | $3.00 |
| AVG Volume (30 Days) | 40.7K | ★ 880.6K |
| Earning Date | 03-12-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $82,551,000.00 | ★ $621,628,844.00 |
| Revenue This Year | $32.58 | $4,290.41 |
| Revenue Next Year | $20.68 | $8.04 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 129.04 | ★ 1534.99 |
| 52 Week Low | $1.10 | $1.12 |
| 52 Week High | $5.48 | $2.10 |
Technical Indicators
Market Signals| Indicator | CLLS | CANG |
|---|---|---|
| Relative Strength Index (RSI) | 32.21 | 34.11 |
| Support Level | $4.04 | $1.28 |
| Resistance Level | $3.95 | $1.38 |
| Average True Range (ATR) | 0.21 | 0.08 |
| MACD | -0.06 | -0.01 |
| Stochastic Oscillator | 0.00 | 9.76 |
Price Performance
Historical ComparisonAbout CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About CANG Cango Inc. each representing two (2)
Cango Inc through its subsidiaries, variable interest entities (VIEs), and subsidiaries of the VIEs, are principally engaged in the bitcoin mining business, and the automobile trading transaction, automotive financing facilitation, and aftermarket service facilitation businesses (collectively, the automobile and related businesses). The Company conducts the bitcoin mining business mainly through its subsidiaries, and the automobile and associated businesses are conducted through the Company's VIEs and the subsidiaries of the VIEs. The company derives the majority of its revenue from the bitcoin mining business.